| Schedule of Fair Value of Foreign Currency Exchange Contracts |
The following table sets forth the aggregate notional principal amounts of outstanding foreign currency forward contracts for derivatives not designated as hedging instruments: | | | | | | | | | | | | | | | | | As of | | Foreign currency forward contracts denominated in: | | September 30, 2026 | | December 31, 2025 | | Sell USD | | 262,105 | | | 217,040 | | | Sell GBP | | 37,287 | | | 35,962 | | | Sell EUR | | 7,089 | | | 7,722 | | | Sell AUD | | 2,958 | | | 4,917 | | | | | | | | Buy USD | | 3,296 | | | 1,837 | | | | | | |
The following table sets forth the fair value of the foreign currency forward contracts and their location on the consolidated balance sheets: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Derivatives in cash flow hedging
relationships | | Derivatives not designated as hedging
instruments | | | As of | | As of | | | September 30, 2026 | | December 31, 2025 | | September 30, 2026 | | December 31, 2025 | | Assets: | | | | | | | | | | Other current assets | | $ | 2,783 | | | $ | 4,444 | | | $ | 56 | | | $ | 196 | | | Other assets | | $ | 661 | | | $ | 1,424 | | | $ | — | | | $ | — | | | Liabilities: | | | | | | | | | Accrued expenses and other
current liabilities | | $ | 33,443 | | | $ | 15,383 | | | $ | 344 | | | $ | 60 | | | Other non-current liabilities | | $ | 13,197 | | | $ | 9,765 | | | $ | — | | | $ | — | |
|
| Schedule of Effect of Foreign Currency Exchange Contracts on Consolidated Statements of Income |
The following table sets forth the effect of foreign currency forward contracts on AOCI and the unaudited consolidated statements of income:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended September 30, | | Nine months ended September 30, | | Derivative financial instruments: | | 2026 | | 2025 | | 2026 | | 2025 | | Unrealized loss recognized in other comprehensive income (“OCI”) | | | | | | | | | | Derivatives in cash flow hedging relationships | | $ | (8,712) | | | $ | (25,816) | | | $ | (45,759) | | | $ | (10,392) | | | | | | | | | | | | Loss recognized in unaudited consolidated statements of income | | | | | | | | | | Derivatives not designated as hedging instruments | | $ | (2,889) | | | $ | (7,273) | | | $ | (11,603) | | | $ | (8,559) | |
The following table sets forth the location and amount of gain/(loss) recognized in unaudited consolidated statements of income for derivatives in cash flow hedging relationships and derivatives not designated as hedging instruments: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended September 30, | | | 2026 | | 2025 | | | As per unaudited consolidated
statements of
income | | Gain/(loss) on derivative financial instruments | | As per unaudited consolidated
statements of
income | | Gain/(loss) on derivative financial instruments | | Derivatives in cash flow hedging relationships | | | | | | | | | | Location in unaudited consolidated statements of income where gain/(loss) was reclassified from AOCI | | | | | | | | | | Revenues, net | | $ | 633,959 | | | $ | 186 | | | $ | 529,585 | | | $ | (816) | | | Cost of revenues | | $ | 392,824 | | | (7,976) | | | $ | 325,649 | | | (764) | | | General and administrative expenses | | $ | 79,872 | | | (989) | | | $ | 66,251 | | | (99) | | | Selling and marketing expenses | | $ | 53,542 | | | (131) | | | $ | 46,383 | | | (21) | | | Depreciation and amortization expense | | $ | 18,865 | | | (204) | | | $ | 15,128 | | | 64 | | | | | | | | | | | | Total before tax | | | | (9,114) | | | | | (1,636) | | | Income tax effects on above | | | | 1,840 | | | | | 354 | | | Net of tax | | | | $ | (7,274) | | | | | $ | (1,282) | | | | | | | | | | | | Derivatives not designated as hedging instruments | | | | | | | | | | Location in unaudited consolidated statements of income where gain/(loss) was recognized | | | | | | | | | | | | | | | | | | | Foreign exchange gain/(loss), net | | $ | 1,502 | | | $ | (2,889) | | | $ | (1,013) | | | $ | (7,273) | | | | | | | | | | |
The following table sets forth the location and amount of gain/(loss) recognized in unaudited consolidated statements of income for derivatives in cash flow hedging relationships and derivatives not designated as hedging instruments: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Nine months ended September 30, | | | 2026 | | 2025 | | | As per unaudited consolidated
statements of
income | | Gain/(loss) on derivative financial instruments | | As per unaudited consolidated
statements of
income | | Gain/(loss) on derivative financial instruments | | Derivatives in cash flow hedging relationships | | | | | | | | | | Location in unaudited consolidated statements of income where gain/(loss) was reclassified from AOCI | | | | | | | | | | Revenues, net | | $ | 1,799,073 | | | 325 | | | $ | 1,545,064 | | | $ | (1,844) | | | Cost of revenues | | $ | 1,109,894 | | | (19,154) | | | $ | 953,626 | | | (817) | | | General and administrative expenses | | $ | 223,359 | | | (2,357) | | | $ | 185,217 | | | (127) | | | Selling and marketing expenses | | $ | 150,371 | | | (318) | | | $ | 127,754 | | | (30) | | | Depreciation and amortization expense | | $ | 47,472 | | | (339) | | | $ | 42,740 | | | 138 | | | | | | | | | | | | Total before tax | | | | (21,843) | | | | | (2,680) | | | Income tax effects on above | | | | 4,507 | | | | | 571 | | | Net of tax | | | | $ | (17,336) | | | | | $ | (2,109) | | | | | | | | | | | | Derivatives not designated as hedging instruments | | | | | | | | | | Location in unaudited consolidated statements of income where gain/(loss) was recognized | | | | | | | | | | | | | | | | | | | Foreign exchange gain/(loss), net | | $ | 4,246 | | | $ | (11,603) | | | $ | 2,390 | | | $ | (8,559) | | | | | | | | | | |
|